Using HTA to lead decision on the use of adjuvanted trivalent inactivated influenza vaccine in Italy [Oral Presentation]

Chiara De Waure, P Bonanni, D Panatto, M Barbieri, Andrea Poscia, S Boccalini, Stefano Capri, Maria Luisa Di Pietro, Maria Lucia Specchia, R Gasparini

Risultato della ricerca: Contributo in rivistaAbstract

Fingerprint

Entra nei temi di ricerca di 'Using HTA to lead decision on the use of adjuvanted trivalent inactivated influenza vaccine in Italy [Oral Presentation]'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science